Simcere Pharmaceutical Co., Ltd

This study tested a new medication called SIM0718 in 259 adults and teenagers (ages 12-75) with moderate to severe atopic dermatitis (eczema) that didn't respond well to topical treatments. The goal was to see if the drug could improve skin symptoms like redness and itching bette…

This study tested a single dose of SIM0718 injection in 178 healthy adults in China to see how the drug moves through the body, how safe it is, and whether it triggers an immune response. Participants were healthy men and women aged 18 to 50. The goal was to gather basic informat…